Sandra Sermone's ten-year-old son Tony was born with ADNP syndrome, an autism-related genetic disorder so rare that when Sermone first read the medical literature, only ten cases had been documented worldwide. Ten children. Ten families scattered across the globe, each one isolated in their own private bewilderment, each one hearing the same thing from their doctors: we do not know enough about this condition to help you.
Sermone read the foundational research publication on ADNP syndrome approximately fifty times. "I read that publication probably 50 times," she said. "And I ended up saying I need to find these 10 parents."
She did not have a medical degree. She did not have a research grant. She had a laptop, an internet connection, and the specific fury of a mother whose child had been sorted into a category too small for the medical establishment to prioritize.
What Sermone built was remarkable. She created her own database. She built a website. She established a patient registry. And then she started hunting. She tracked down families across countries and continents, connecting parents who had never known anyone else dealing with the same diagnosis. The ten known cases became twenty, then fifty, then a hundred. Sermone ultimately identified more than one hundred and fifty children with ADNP syndrome globally -- a patient population that the medical community had not assembled because no one had thought to look.
The emotional weight of that discovery hit the families hard. Victoria Malvagno, one of the parents Sermone connected, described the experience simply: "It's very emotional. A lot of times you feel like you are alone as parents." Genie Egerton-Warburton, another parent brought into the network, called the gathering of ADNP families "heartwarming and amazing."
But Sermone was not building a support group. She was building a research infrastructure. The patient registry she assembled caught the attention of Mount Sinai Hospital, which launched a new study based on the data. Dr. Joseph Buxbaum, director of the Seaver Autism Center, said the goal was to "figure out the biology of this disorder and other similar disorders, so that we can come up with new drugs that are targeted to the disorder."
Sermone did not stop at data collection. She co-authored five research papers. A mother with no formal scientific training became a published researcher because she refused to accept that her son's condition was too obscure to study. The FDA eventually designated a new drug as a potentially first treatment option for ADNP syndrome -- a designation that would not exist without the patient population Sermone single-handedly identified.
"Even if it's not for Tony," Sermone said, "if one family can make this stop, it will all be worth it."
That sentence is the whole story. Sermone did not build a global patient registry to save her own son. She built it because no child should have a condition so invisible that doctors cannot even find enough patients to study it. She filled her mind with the needs of a hundred and fifty families she had never met, and in doing so, she moved a disorder from medical footnote to active research pipeline.
At Hero.me, the Service Paradox describes how you conquer your own dragon by helping someone else conquer theirs. Sermone is its textbook case. She started by trying to understand her son's diagnosis. She ended up giving the entire ADNP community something it had never had: visibility, data, and a path toward treatment. The heroism here is not dramatic. It is a woman reading the same paper fifty times and then deciding she would find the other nine families herself. That is how a mother rewrites the medical literature.